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ABSTRACT
Purpose: A multicenter study was undertaken to evaluate the safety, efficacy and cost of
electromotive drug adrninistration of intravesical Iidocaine to produce bladder local 
^nesthesia as
an alternative to traditional methods of spinal or general anesthesia.
Materials and Methods: A total of 94 patients were enrolled in the study who had either a history
of bladder tumor that requid cold cup bladder biopsy with firlguration for possible riesurence as a
comparison trial, a bladder tumor treated with transurethral resection/fulguration or benign pros-
tatic hyperplasidcalcinoma treated with transurethral resection. Pain scores psing aVerbal Rating
Scale were recorded for each individual biopsy, fulguration and resection event. Data for direct and
indirect oosts wer€ mllect€d using a standadized forn for each patient to capture the details of the
pmcedure, including times, drugs and disposables for each patient.
Results: There was a significant reduction in pain for patients who received electromotive intra-
vesical lidocaine compared to no anesthesia for biopsy (p <0.03). Similarly, electromotive intravesical
lidocaine for bladder biopsy and transurethral bladder tumor resection/fulguration was associated
with higher patient satisfaction compared to previous treatments (p <0.00002). In contrast, electro-
motive intravesical lidocaine was insufrcient for 3 of 6 hansurethral prostatic resections. The cost
per patient was about $146 Cdn less with elechomotive intravesical lidocaine than with conventional
generaVspinal anesthesia.
Conclusions: Electromotive intravesical lidocaine may be a safe, effective and affordable forrn
of anesthesia for the ambulatory care of patients requiring transurethral bladder biopsy, resec-
tion or fulguration with a poteutial for cost savings.
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Traditional techniques for trangurethral resection use gen-
eral and spinal anesthesia that is typically applied in an
inpatient environment. Moet of the prooedures are of short
duration but, given the conplerity of these forns of anesthe-
sia, many are undertaken in the operating room and costs are
high. Locoregional anesthetic alternatives include intraure-
thral,r intravesical lidocaine,z'3 transuretbral needle blocks
to urethra, bladder nech and bladder wall,a and percutaneous
periprostatic and pudendal nen'ey'saddle blocks. However,
attempts to block pain from the bladder with intravegical
lidocaine have not been widely adopted because ofthe short
duration of anesthesia and generally poor passive diffirsion
acrogs the impermeable urothelium.6 Electromotive drug ad-
ministration offers a solutiou to these limitations.6'7 Sigdfi-
cant benefits could be achieved by reducing main operating
roon time and minimizing the need for inpatient stay. Fur-
thermore, current anesthesia techniques have associated
risks and side effects, particularly in an elderly population.
Locoregional anesthesia for transurethral surgery may be
possible with electromotive administration of intravesical
lidocaine to enhance drug delivery.c A direct pulsed current
across the bladder mucosa moves high concentrations of ion-
izcd lidocaine into the bladder wall by several electrokinetic
forces. In particular, drug penetration is enhanced by ionto-
phoresis (active transport of ionized drug down an electrical
gradient of appropriate pslarity), electro-osmosis (ionized or
nonionized drug transport accelerated by convective flow of
water due to current induced movement ofother ions) and
electroporation (increased permeability due to direct electri-
cal effects on biological membranes that permit increased
transport down concentration Bradients).a-r0 lontophoresis is
the predominant electrokinetic force involved in the trans-
port oflocal anesthetic drug.tr
Electromotive drug adninistration has been studied in
animal systems, and used to deliver intravesical local anes-
thetic agents for transurethral surgery, Examples include
transurethral microwave thermotherapy of benigrr prostatic
hyperplasia, hy&ostatic distention of the bladder for inter-
stitial cystitis, delivery of mitomycin and &aminolevulinic
acid for bladder cancer, and oxybutynin for hyperreflex-
ia.6' 12-16 Tlansdermal electromotive application of drugs, in-
cluding morphine and dexamethasone as well as many other
agents, has also been reported,e
MATERIALS AND METHODS
A multicenter study of 94 patients was undertaken to
assess the safety, efficacy and cost-effectiveness ofelectromo-
tive administration ofintravesical lidocaine as an alternative
to spinal or general anesthesia. lhree centers and 3 groups
of patients participated in the study. Group 1 comprised 45
patients who required cold cup bladder biopsy with (27) or
without (18) electromotive intravesical lidocaine as a com-
parison trial of electromotively administered lidocaine versus
no anesthesia. These 2 consecutive cohorts represented all
biopsy patients during the study period and all underwent
fulguration of the biopsy sites. This group also included 6
patients with concurrent bladder tumor and interstitial cys-
titis.who re-quired bladder biopsyrhydrodistention. Groui Z
consisted of 43 patients undergoing transurethral resection/
fulguration who were offered electromotively administered
lidocaine as an alternative to general or regional atesthesia.
Group 3 included 6 men with benign prostatic hyperplasia(BPH)/carcinoma of prostate undergoing transurethral ieeec-
tion who agreed to be treated with electromotively adminis-
tered lidocaine.
Patients with known enlargement of the median prostate
lobe were excluded from study because of potential aimcUty
inserting the stiffer catheter containing the electrode. Pa-
tients with active hematuria and inflammatory/urinary tract
infections also were excluded from study to avoid possible
excess lidocaine absorption. In addition, known allergy or
sensitivity to any ofthe medications used, apparent psycho-
logical instability and pregnancy were exclusion criteria.
The generator was a battcry powered, current controlled,
programmable Physionizer 30+ with a range of 0 to 30 mA.
and options of constant or pulsed direct current (2-5 kllz.),
the latter being more efficient.o' rr Ihe tranwesical transmis-
sion of current was achieved with the commercially available
CE-DAS* catheter of traditional Foley design but containing
a central silver coated electrode acting as an anode. For
womeD the catheter was modified with 3 pairs of opposing
side holes in the tip distal tp the balloon to allow adequate
exposure of the electrode. For men the catheter had a similar
series of side holes in the prostatic urethral section plus a
pair oflarger side holes in the region ofthe bladder neck.
Patients were instructed to restrict fluids 6 to 12 houns
before the procedure to minimize urina4r dilution of the
lidocaine instillate and introduction of charge competitive
ions. As clinically indicated, l to 2 mg. sublingual lorazepam
were administered as an anxiolytic to 507o of the biopsy and
90Vo of the transurethral bladder tumor resection/fulguration
patients. Clinical judgment was used to select the percentage
of electromotive intravesical lidocaine patients and percent-
age of controls to receive lorazepam. This agent was not
observed to alter patient ability f4r geglprrni6ste. Anesthetic
gel was instilled into the urethra and no additional analgesia
was given unlees treatment failed. Sodium chloride-free 100
ml. lidocaine 4Vo were mixed with 100 ml.) sterile water and
2 ml. epinephrine (1 mgJml.) for a 6nal concentration of
1:100,000.
The bladder was cathetenzed with the appropriate male or
female catheter, drained and irrigated with 100 ml. sterile
water to check for hematuria. Immediately 150 ml. of the
drug solution to maximize even dnrg distribution at the op-
timal ratio of surface area-to-volume were instilled. The dis-
persive cathode electrodes were placed on aMominal or thigh
skin that had been degreased with alcohol wipes and a2 io 5
mm. layer of conductive gel was applied. Air bubbles were
eliminated by pressing and sliding the saline impregnated
dispersive electrodes gently side to side to avoid skin injury'
The pulsed current was then activated and increased pro-
gressively (40 to 60 pA. per second to a maximum of 25 mA'
for 20 to 25 minutes, total charge about 600 rr.A.). Every 5
minutes the catheter was rotatd 90 degrees to expose fresh
areas ofthe prostatic urethra (for consistency, this was also
done in wornen). About 50 ml. were withdrawn at the first
quarter turn and reinfusetl to circulate the instillate and
check for hematuria. About 50 to 60 ml. instillatc wer€ re-
moved at the second turr to minimize dilution by new urine
and replaced with 50 ml. fresh drug solution.
Safety agsessment was done by calculating an American
Society ofAnesthesia score and recording adverse events for
each patient. A numeric pain ecore was rDeaaurd before,
* Physion Srl., Mirandola, Italy.
during and after the procedures using an ll-point numeric
rating scale with end points labeled 0 (no pain) and l0 (worst
possible-pain).17 Patients were familiarized with the pain
scale before treatment and asked to provide a rating between
0 and 10 of the pain they experienced at haseline (before,
during and after insertion ofthe cystoscope), at each biopsy
or tumor excision (before, during and aft.er), during coaguta-
tion or resection and at discharge from the cyetoscopy suite.
Patients were also asked to score the overall level ofcomfort
from 0 to 10 and rate whether they would repeat the proce-
dure io the same manner using the seme technique ofanes-
thesia.
Demographic featuree and clinical variabtes were recorded
as mean, standard deviation, median and interquartile range
or frequeucy. For bladder biopsy @roup 1) demographic &a-
tures and clinical variables were compared between the elec-
tromotive irntravesical lidocaine and control groups by un-
paired t test for ratio scale data. Chi-square test w.ith Yatee,
continuity correction was used to analyze frequency data, To
get a compreheneive evaluation of pain, data were sum.rsa-
rized as median prin e16 peak pain with interyuartile range.
Pain scores were compared between the groups by tLt
Wilcoxon tcst. The proportion of patients willing toundirgo a
repeat procedure w€a compared between the groups by chi-
square test with Yat€s' continuity correction. lko.tailed
tests were used with p <0.05 considered statistically signif-
rcanD.
Given the nascent character of the technologl, preliminarJr
economie estimates were derived from modeling rather than
direct observation. Cost data were cullected using a stan-
dardized form for each patient to capture the details ofthe
procedure, including times, dnrgs and dieposablee. ?he eco-
nomic analysis was done from the societal perspective and all
amounts were expressed in 1997 Canadian dollare. The 5
simpliSing assumptions eEsential for the analysis were l)
iontophoresie saves money by avoiding conventional anesthe-
sia, 2) iontophoresis costs money primarily through the con-
sumption of disposables and partially through the coet of
acquiring durable equipment, 3) the procedure when effec-
tive is as successful as conventional anesthesia and yields
similar downstream outcomes, 4) the procedur.e wheu not
effective allows for switching the patient over to traditional
anesthesia with no extra difEculties and 5) the marginal cnst
of extra time related to using iontophoreeis is negligible. Ihe
cost of spinal and geueral anesthesia wae estimated by con-
sidering the typical charge for an anesthesiologist snd the
typical expenditures for the operating room, medications in
the operating room and post-anesthetic monitoring. The
main assumption is that these costs would be avoided by
iontophoresis. Anesthesiologist charges were obtained from
the Ontario Ministry of Health Schedule of Benefits. Medi-
cation costs were obtained from The Toronto Hospital phar-
macy. Miscellaneous expenses, such as intravenous sets,
electrocardiogram leads and paper records, were aes'med Lo
be sufficiently similar in spinal and electromotively delivered
anesthesia to be excluded from calculations ofmarginal costs.
RESULTS
Most patients reported local tingling sensations when t}re
current was applied and had some cutaneous erythema at
the site where the dispersive cathode electrode was attached
to the skin. Both reactions disappeared within t hour except
in I patient who experienced a second degr.ee bur:n at 1 of 2
electrode sit€s, which subsequently healed spontaneously.
Mucosal blanching or "brandingl was noted at the bladder
neck or in the prostatic urethra in a few patients wbere the
electrode was touching the mucosa at the catheter eyelet. No
distortions were noted ia the histologl of any of the biopoy
specimene that could be attributed to iontophoregig or lido-
caine.
Demographic and clinical variables for group I were simi-
lar for those who did or did not receive electromotive intra-
vesical lidocaine (control group) (table 1). Pain levels were
similar before the procedures but were siglificantly less in-
tense for the electromotive drug administration group than
the control group during insertion ofthe cystoscope, biopsy
and coagulation (table 2). Also peak pain during biopsy was
significantly less in the electromotive than the control group.
A significantly greater proportion ofpatients in the electro-
motive than in the control gxoup stated that they would be
willing to repeat the procedure (table 1).
For the group 2 patients undergoing transurethral bladder
tumor resection/fulguration demographic, clinical variables,
and median and peak pain scores during the procedure are
shown in tables 3 and 4. Except for mild pain during cutting(median pain score 1.4), median pain scores for the entire
procedure were 0. However, 25Vo ofpalients had pain scores
greater than 3 during tumor excision artd,2|?o had peak pain
scores greater than 5. The majority ofpatients (867o) stated
that they would be willing to repeat the pmcedure. Of the
group 3 patients who underwent transurethral prostatic re-
section with iontophoresis 3 experienced more discomfort
than those undergoing bladder procedures. The remaining 3
patients had remarkably pain-free procedures.
The cost of electromotive intravesical lidocaine included
purchasing 1 generator ($2,600), I specially designed elec-
trode ($250), anesthetic ($4.?0 per 50 e vial lidocaine 47o)
and other nedications ($0.50 per vial epinephrine 1:1,000).
The analysis assumed that the generator can be used for at
least lfi) treatments before needing replacement or repair
and, hence, generator costs per treatment were $26 or less.
One nonreueable catheter was assusred to be used for each
treatment, along with 2 vials of lidocaine and 2 vials of
epinephrine, leading to estimated marginal costs of $286.
The costs for doing the same procedures in the operating
room with spinal or general anesthesia were estimated and
included $120 for an anesthesiologrst, $212 for the operating
room, $50 for medications in the operating room and $50 for
postanesthetic monitoring, for a total of $432. Therefore,
electromotive intravesical lidocaine was $146 cheaper to per-
form ($432-$286).
DISCUSSION
In this study the 70 patients who underwent bladder bi-
opsy and transurethral bladder tumor resection/fulguration
received good anesthesia but 3 ofthe 6 men who underwent
transurethral prostatic resection with electroraotive intra-
vesical lidocaine experienced substantial discomfort and the
result was unpredictable. Giirpinar et al noted that in a
canine model using iontophoresis and methylene blue, dye
penetration was less in the bladder neck and prostate com-
pared to the bladder wall.lr The same result might be ex-
pected with lidocaine in humans although the catheter is
designed to expose this area to the current. Further modifi-
Tant,n 1. Demographic features and clinical uariables for group 1
pati4nts pretredted with electromotive intravesiral lidacainz or
b iop s ied w ithout ane sthesia
Electromotive
Intravesical Control
Lidocaine
Nc. pts.
% Men
Mem age * SD
Meu kg, wt. * SD (roge)
Mem No. biopsia t SD
Mem No. mgulation : SD
% Repeat procedure:
Yea
No
Tesl,s 2. Efftracy of electromotiue intrauesicol lid.uairc expressed
qs 0 to 10 rating scores a.t uarious timcs before, during and after
- 
bladder biopsl 
_
Eletromotive
Intravesiel Lidocaine
Median Peak Median(IQ range) (IQ range) (IQ range) Peak(IQ range)
Bseline 0 (G{) 0 (M)
Insertion* 0 (0-2) 2 n-5)
Before biopsy 0 (0-1.3) 0 (0-1.5) 0 (0-1.5)
During biopsy' 0 (0-l) I (0-2) 3 (2-5)
A.fter biopsy 0 (0-2) 0 (0-3) 0 (0-2)Coagufationr 0(0-1.4) 0 (0-3) 2(M.4,
End of procedure 0 (G-0) 0 (0-1)Discharge 0(H) 
- 
0(G-0)
i Etectmmoti* ueru;
'Electromotive versus c,ontrol for median and peak pain scores p <0.0001(Wilcoxon test).
t Electrcmotive venw control for peak pain scores p <0.04 (Wilcoxon test).
Tt l 3. Demogrophic features dnd clini.cal uariables for group 2
No. pt.s.
% Men
Meu age : SD
Mean wt. : SD (kg.)
%fupeat prmedure
Tasln 4. Efficacy of elzctromntiue intrauesicol li.dacaine expressed
as 0 to 1O rating scores ot various timcs, during and after blad.dcr
tumor fulguration I resection
Median Pain (IQ range) Peak Pain (IQ range)
Baeline
Imertion
Before ot
During cut
After cut
Coagulation
End of prredure
Discharge
0 (0-2)
5 (3.3-.6)
2 (0-3.5)
3 ( 1.5-7.3)
43
79
69 : 10.2
74 * 18.3
86
0 (H)0 (G-2)0 (0-3)
1.4 (0-3)0 (0-{)
0 (0-1.9)0 iH)0 (H)
_
0 (0-0)3 (1-5)0 (o-{)
0 (o-4.8)
o
27
52
62 i 13.3
75 i 19.8 (3H8)
3.1 J 1.9
5.8 3 9.9
18
72
68 * 13.3
75 t 15.2 (32-85)
3.3 * 1,4
6.3 a 7.5
cation will be necessary for prostate and bladder neck sur-
gery, such as the adjunctive use ofprostate block and intra-
venous sedoanalgesia. Adverse events were either trivial,
such as tingling sensations and minor urothelial coagulation
by the electrode, or limited to infrequent skin effects of the
cathode. Only 1 patient had any morbidity from this skin
effect and that might have been prevented with careful ap
plication of the skin pad. We did not measure intravenous
lidocaine levels but previous reports indicate that little drug
is absorbed from the bladder into the syste6is s11sr141bn.o, rE
We did not evaluate intravesical lidocaine without applied
electrical cunent, We and others have inadvertently used
electromotive drug administration without current and the
patients experienced pain.z Similarly, reversal of polarity
during electromotive lidocaine administration lead to poor
pain control. We believe that reports of local bladder anes-
thesia based on the passive diffi,rsion ofintravesical lidocaine
provide limitetl support for the use of lidocaine alone and this
has never been widely adopted by urologists.r,2 This finding
is not surprising as bladder mucosa is the Ieast permeable
plasma membrane in the human which is important to its
normal function.
It is clear from our experience that patient tolerance of
p-ain varies greatly during bladder biopsy or fulguration and
that some may be reassured by efforts to reduce discomfort.
Therefore, some patients may appear to benefit from pre-
treatment instillation of local anesthetic but no controlled
trial has been conducted to our knowledge. The principal
outcome for comparison was the level of pain perceived by the
patients, for which we used a simple, effrcient and minimally
23
?6
86*
l5
* Chi-square p <0.0002.
intrusive numeric rating pain scale (0 to l0l. This meaaune
has been used widely in research settingc where a guick
index of pain is required 8nd to which a numerical statiotic
can be assigred. It has been shown to be eengitive to inter-
ventions which diminish or augment the experience of pain,
to take a matter of seconds to adminieter and to have excel-
lent validity.r? It is important to note that no patient ecored
received any other analgesia or anesthesia.
The evaluation ofnew surgical tcchnologT reguiree an as-
sessment of cost-effectiveness and needs to consider what
goes on outside lhe operatingroom.ra Expendituree related to
preoperative assessment, followup evaluationc and untoward
events can be substantial. When estimating the marginal
costs of this procedure relative to spinal and general anee-
thesia, however, these costs were agsumed to be sufficiently
stable to contribute equally in both and to disappear in a
comparison between the 2 approaches. This assumption is
reasonable from a health care perspective but it is somewhat
conservative from the individual patient perspective given
that the electromotive technique requires little recovery time
and faster return to usual activity. Actual costs with generaV
spinal anesthesia will depend on local practice to some ext€nt
and may be generally lower in Canada than in the United
States.
Our experience suggests that electromotive drug adminis-
tration will probably not be successful for every patient and
that clinicians may initially have problems in identi$ing
who should be included. Ttrere will be a learning cune for
urologists beginning to use iontophoresis. Failures with ion-
tophoresis are noteworthy, given that spinat and general
anesthesia is almost always dependable. ln our economic
analysis we assumed that when the technique was unauc-
cessful, patients were switched over to spinal or general
anesthesia with no additional difficulty. However, euch fail-
ures may be relatively expensive, given that they invoke the
full cost of both forme of anestheeia. A final limitation of the
technique ie the slow onset ofaction. Instillation reguirea 25
to 30 minutes to allow medication to penetrate the lining of
the urinary tract. Assessing the cost ofauch waiting is protr
Iematic. We currently perform the procedures at an outpa-
lient cystoscopy unit and are persuaded tbat thit anesthetic
technique offers advantagea in terms of safety and c,ost while
providing near equal levele ofanesthesia.
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